Cargando…
DNA vaccine for cancer immunotherapy
DNA vaccination has emerged as an attractive immunotherapeutic approach against cancer due to its simplicity, stability, and safety. Results from numerous clinical trials have demonstrated that DNA vaccines are well tolerated by patients and do not trigger major adverse effects. DNA vaccines are als...
Autores principales: | Yang, Benjamin, Jeang, Jessica, Yang, Andrew, Wu, T C, Hung, Chien-Fu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514137/ https://www.ncbi.nlm.nih.gov/pubmed/25625927 http://dx.doi.org/10.4161/21645515.2014.980686 |
Ejemplares similares
-
Optimization of heterologous DNA-prime, protein boost regimens and site of vaccination to enhance therapeutic immunity against human papillomavirus-associated disease
por: Peng, Shiwen, et al.
Publicado: (2016) -
Buccal injection of synthetic HPV long peptide vaccine induces local and systemic antigen-specific CD8+ T-cell immune responses and antitumor effects without adjuvant
por: Yang, Ming-Chieh, et al.
Publicado: (2016) -
Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research
por: Lee, Sung-Jong, et al.
Publicado: (2016) -
Co-administration with DNA encoding papillomavirus capsid proteins enhances the antitumor effects generated by therapeutic HPV DNA vaccination
por: Yang, Benjamin, et al.
Publicado: (2015) -
Perspectives for therapeutic HPV vaccine development
por: Yang, Andrew, et al.
Publicado: (2016)